Bio Protocol vs Unibase — how do they compare? Bio Protocol trades at Rp514.47 (market cap Rp1,16T, Rp252,63M 24h volume), while Unibase trades at Rp1,360 (market cap Rp3,33T, Rp148,82M 24h volume). The key difference: Unibase is far larger — about 2.9× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 2,5B / 10B UB (25%) for Unibase. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Unibase for 2 Days on average.
| BIO | UB | |
|---|---|---|
Market Cap | Rp1,16T | Rp3,33T |
Volume (24h) | Rp252,63M | Rp148,82M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 2,5B / 10B UB (25%) |
Typical Hold Time | 16 Days | 2 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Unibase is a decentralized AI infrastructure protocol that provides autonomous agents with persistent memory, interoperability, and self-evolution capabilities. It addresses agent statelessness and data silos by providing a decentralized memory layer that combines verifiable storage, cross-agent communication, and high-speed data availability. UB is used for protocol fees, governance, staking, and knowledge-based rewards.
Read more on UB →